Incontinence and Ostomy Care Products Market Outlook

Valued at USD 16.99 billion in 2024, the incontinence and ostomy care products market is projected to reach USD 17.88 billion in 2025 and USD 28.53 billion by 2034, growing at a CAGR of 5.33% during the forecast period 2025–2034. Demand is propelled by the expansion of home care, advances in product technology, a rising elderly demographic, and a higher prevalence of long-term conditions. Key players include B. Braun SE; BD (Becton Dickinson); Byram Healthcare Centers, Inc; CliniMed Limited; Coloplast Corp (SenSura, Assura brands); Convatec Group PLC; Essity; Hollister Incorporated; Salts Healthcare; and Welland Medical Ltd.

Aging Population Expands Demand

The rising aging population is a primary driver, as elderly individuals are more prone to urinary incontinence, colorectal cancer, and other gastrointestinal disorders that often require ostomy procedures. According to a February 2025 World Health Organization report, the global population aged 60 years and above is expected to rise from 1.1 billion in 2023 to 1.4 billion by 2030. Muscle tone weakens and mobility limitations increase with age, making basic toileting needs harder to manage without assistance. This shift has increased demand for reliable, comfortable solutions that support independent living, and manufacturers are focusing on ergonomic, discreet, and skin-friendly designs.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/incontinence-and-ostomy-care-products-market

Chronic Diseases Sustain Long-Term Product Use

The rising prevalence of chronic diseases such as diabetes, cancer, inflammatory bowel disease, and neurological disorders contributes to higher adoption. An October 2024 CDC report stated that chronic diseases such as heart disease, cancer, and diabetes are the top causes of U.S. deaths and disabilities, with six in 10 Americans having at least one chronic condition and four in 10 having multiple. Many of these conditions lead to complications that impair bowel or bladder function, necessitating long-term or permanent use of specialized medical devices. The growth of chronic diseases across age groups creates a consistent and growing need for these products. In India, rising lifestyle-related conditions such as diabetes and obesity are also supporting expansion.

Home Healthcare Reshapes Product Requirements

The expansion of home healthcare is transforming how patients access and use care. More individuals, particularly the elderly and chronically ill, prefer care in the comfort of their homes, increasing demand for convenient, easy-to-use, and reliable products. This has encouraged manufacturers to prioritize user-friendly designs for self-administration or support by non-professional caregivers, contributing to better outcomes and a more cost-effective care environment. In Europe and the UK, ongoing investment in home-based care services and NHS promotion of cost-effective solutions are reinforcing this shift.

Product Innovation and Odor Control

Continuous product innovation is creating growth opportunities. Manufacturers are integrating odor control, skin-friendly materials, enhanced absorbency, and discreet designs to improve comfort and reduce complications. In February 2024, Convatec launched Esteem Body with Leak Defense, a one-piece convex ostomy system. In May 2024, Coloplast enhanced its Luja catheter line for women, designed to enable complete bladder emptying without repositioning and using 28% less plastic. In April 2024, Medline collaborated with Consure Medical to exclusively distribute the QiVi MEC male external catheter, designed to reduce catheter-associated urinary tract infections and incontinence-associated dermatitis. Innovations in digital monitoring and smart healthcare devices are further enhancing the user experience in clinical and home environments.

Cost and Reimbursement Constraints

High product costs and limited reimbursement policies in developing markets restrict accessibility, particularly for elderly and low-income populations. However, awareness of advanced, skin-friendly products in emerging economies presents untapped potential as healthcare standards rise and aging populations expand. Asia Pacific is projected to grow fastest from 2025 to 2034, while North America led in 2024.

Strategic Outlook

Manufacturers that pair innovation with affordability and home-care accessibility are positioned to capture growth at the 5.33% CAGR projected through 2034. The segment mix remains led by
incontinence and ostomy care products, which held a 75.0% revenue share in 2024, while North America's refined healthcare framework, high awareness, and concentration of manufacturers sustain its regional lead.

More Trending Latest Reports By Polaris Market Research:

top-20-companies-driving-change-in-edible-oil-market-2025

nicotine-pouches-market

sovereign-cloud-market

create-engaging-marketing-videos-with-ai-video-generator-market

competitive-analysis-of-top-10-companies-in-the-bioinformatics-market-2025

advancing-immunotherapy-with-top-5-immunotherapy-drug-companies

tobacco-packaging-market

us-lithium-market

diphenylmethane-diisocyanate-mdi-market